Peapod Lane Capital LLC
Source: SEC Form 13F · as of Mar 2026Peapod Lane Capital LLC holds 9 biotech & pharma companies tracked by BioSniper, totaling $11.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$11.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Fulgent Genetics Inc. (FLGT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| FLGTFulgent Genetics Inc. | 220,627 | $3.5M |
| FDMT4D Molecular Therapeutics, Inc. | 241,480 | $2.2M |
| PLRXPLIANT THERAPEUTICS, INC. | 1,288,578 | $1.6M |
| KZRKezar Life Sciences, Inc. | 126,692 | $925K |
| ZNTLZentalis Pharmaceuticals, Inc. | 366,868 | $835K |
| CLYMClimb Bio, Inc. | 108,878 | $740K |
| MGXMetagenomi Therapeutics, Inc. | 516,761 | $683K |
| BCYCBICYCLE THERAPEUTICS PLC | 121,106 | $550K |
| ANTXAN2 Therapeutics, Inc. | 59,854 | $207K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.